Sing P. Chan

Array ( [id] => 1570037 [patent_doc_number] => 06498014 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-24 [patent_title] => 'Monoclonal antibodies that recognize antigens associated with tumor metastasis' [patent_app_type] => B1 [patent_app_number] => 09/499781 [patent_app_country] => US [patent_app_date] => 2000-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 39 [patent_no_of_words] => 14880 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/498/06498014.pdf [firstpage_image] =>[orig_patent_app_number] => 09499781 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1197327 [patent_doc_number] => 06727349 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-04-27 [patent_title] => 'Recombinant anti-CCR2 antibodies and methods of use therefor' [patent_app_type] => B1 [patent_app_number] => 09/497625 [patent_app_country] => US [patent_app_date] => 2000-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 64 [patent_no_of_words] => 46639 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 45 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/727/06727349.pdf [firstpage_image] =>[orig_patent_app_number] => 09497625 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1391700 [patent_doc_number] => 06541225 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-01 [patent_title] => 'Methods and compositions for generating human monoclonal antibodies' [patent_app_type] => B1 [patent_app_number] => 09/491894 [patent_app_country] => US [patent_app_date] => 2000-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14903 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 156 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/541/06541225.pdf [firstpage_image] =>[orig_patent_app_number] => 09491894 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1415770 [patent_doc_number] => 06521593 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-18 [patent_title] => 'Methods for inhibiting brain tumor growth' [patent_app_type] => B1 [patent_app_number] => 09/489391 [patent_app_country] => US [patent_app_date] => 2000-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 11367 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/521/06521593.pdf [firstpage_image] =>[orig_patent_app_number] => 09489391 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1245073 [patent_doc_number] => 06676927 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-01-13 [patent_title] => 'Animal model and methods for its use in the selection of cytotoxic antibodies' [patent_app_type] => B1 [patent_app_number] => 09/481175 [patent_app_country] => US [patent_app_date] => 2000-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 24 [patent_no_of_words] => 9291 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/676/06676927.pdf [firstpage_image] =>[orig_patent_app_number] => 09481175 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1542066 [patent_doc_number] => 06372441 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-16 [patent_title] => 'Method for diagnosis and therapy of Hodgkin\'s lymphomas' [patent_app_type] => B1 [patent_app_number] => 09/331254 [patent_app_country] => US [patent_app_date] => 1999-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 8816 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/372/06372441.pdf [firstpage_image] =>[orig_patent_app_number] => 09331254 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6529896 [patent_doc_number] => 20020136716 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-26 [patent_title] => 'COMPOSITIONS AND METHODS FOR ALTERING CELL MIGRATION' [patent_app_type] => new [patent_app_number] => 09/459749 [patent_app_country] => US [patent_app_date] => 1999-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7918 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20020136716.pdf [firstpage_image] =>[orig_patent_app_number] => 09459749 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1127340 [patent_doc_number] => 06790938 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-09-14 [patent_title] => 'Anti-GPIIb/IIIa recombinant antibodies' [patent_app_type] => B1 [patent_app_number] => 09/424840 [patent_app_country] => US [patent_app_date] => 1999-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 20914 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 184 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/790/06790938.pdf [firstpage_image] =>[orig_patent_app_number] => 09424840 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7643745 [patent_doc_number] => 06429295 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-06 [patent_title] => 'Monoclonal antibody which recognizes the oligosaccharide N-glycolylated-galactose-glucose sialic acid in malignant tumors, and composition containing it' [patent_app_type] => B1 [patent_app_number] => 09/402521 [patent_app_country] => US [patent_app_date] => 1999-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 6521 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/429/06429295.pdf [firstpage_image] =>[orig_patent_app_number] => 09402521 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7636947 [patent_doc_number] => 06379708 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-30 [patent_title] => 'Method for enhancing immune responses in mammals' [patent_app_type] => B1 [patent_app_number] => 09/444144 [patent_app_country] => US [patent_app_date] => 1999-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5952 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/379/06379708.pdf [firstpage_image] =>[orig_patent_app_number] => 09444144 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1290353 [patent_doc_number] => 06632926 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-10-14 [patent_title] => 'Antibody variants' [patent_app_type] => B1 [patent_app_number] => 09/440781 [patent_app_country] => US [patent_app_date] => 1999-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 5 [patent_no_of_words] => 28115 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/632/06632926.pdf [firstpage_image] =>[orig_patent_app_number] => 09440781 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1597010 [patent_doc_number] => 06492498 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-10 [patent_title] => 'Multimeric immunotoxins' [patent_app_type] => B1 [patent_app_number] => 09/440344 [patent_app_country] => US [patent_app_date] => 1999-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 12 [patent_no_of_words] => 15360 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/492/06492498.pdf [firstpage_image] =>[orig_patent_app_number] => 09440344 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6570922 [patent_doc_number] => 20020165363 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-07 [patent_title] => 'CACHEXIA REMEDY' [patent_app_type] => new [patent_app_number] => 09/423800 [patent_app_country] => US [patent_app_date] => 1999-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 24406 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20020165363.pdf [firstpage_image] =>[orig_patent_app_number] => 09423800 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1062681 [patent_doc_number] => 06849425 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-02-01 [patent_title] => 'Methods of optimizing antibody variable region binding affinity' [patent_app_type] => utility [patent_app_number] => 09/434870 [patent_app_country] => US [patent_app_date] => 1999-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 16293 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 380 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/849/06849425.pdf [firstpage_image] =>[orig_patent_app_number] => 09434870 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1305827 [patent_doc_number] => 06617115 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-09-09 [patent_title] => 'Methods of screening for modulators of cell proliferation' [patent_app_type] => B1 [patent_app_number] => 09/428156 [patent_app_country] => US [patent_app_date] => 1999-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 26858 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 156 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/617/06617115.pdf [firstpage_image] =>[orig_patent_app_number] => 09428156 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1494976 [patent_doc_number] => 06342587 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-29 [patent_title] => 'A33 antigen specific immunoglobulin products and uses thereof' [patent_app_type] => B1 [patent_app_number] => 09/425638 [patent_app_country] => US [patent_app_date] => 1999-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 11 [patent_no_of_words] => 16199 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/342/06342587.pdf [firstpage_image] =>[orig_patent_app_number] => 09425638 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1406795 [patent_doc_number] => 06534633 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-18 [patent_title] => 'Polyspecific binding molecules and uses thereof' [patent_app_type] => B1 [patent_app_number] => 09/422375 [patent_app_country] => US [patent_app_date] => 1999-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 38 [patent_no_of_words] => 37086 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/534/06534633.pdf [firstpage_image] =>[orig_patent_app_number] => 09422375 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6986815 [patent_doc_number] => 20010036647 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-11-01 [patent_title] => 'FUNCTIONALLY ASSEMBLED ANTIGEN-SPECIFIC INTACT RECOMBINANT ANTIBODY AND A METHOD FOR PRODUCTION THEREOF' [patent_app_type] => new [patent_app_number] => 09/425075 [patent_app_country] => US [patent_app_date] => 1999-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9549 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20010036647.pdf [firstpage_image] =>[orig_patent_app_number] => 09425075 [rel_patent_id] =>[rel_patent_doc_number] =>)